Dennis Ding
Stock Analyst at Jefferies
Total Price Targets
9
Stocks Covered
8
Sectors
Healthcare
Most Recent
Mar 13, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Dennis Ding
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | $30.00 | $29.07 | +3.2% | 1 | Mar 13, 2026 |
| SGP | SpyGlass Pharma, Inc. Common Stock | $62.00 | $24.27 | +155.5% | 1 | Mar 3, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $125.00 | $82.41 | +51.7% | 2 | Mar 3, 2026 |
| FOLD | Amicus Therapeutics, Inc. | $14.50 | $14.49 | +0.1% | 1 | Jan 22, 2026 |
| ARDX | Ardelyx, Inc. | $8.00 | $6.93 | +15.4% | 1 | Jan 2, 2025 |
| IKT | Inhibikase Therapeutics, Inc. | $8.00 | $1.90 | +322.2% | 1 | Nov 8, 2024 |
| ASMB | Assembly Biosciences, Inc. | $35.00 | $27.64 | +26.6% | 1 | Sep 20, 2024 |
| RXRX | Recursion Pharmaceuticals, Inc. | $6.00 | $3.42 | +75.7% | 1 | Sep 3, 2024 |
Recent Activity
- Mar 13, 2026— Set$30.00price target onMLYS(Mineralys Therapeutics, Inc.)
- Mar 3, 2026— Set$62.00price target onSGP(SpyGlass Pharma, Inc. Common Stock)
- Mar 3, 2026— Set$125.00price target onRYTM(Rhythm Pharmaceuticals, Inc.)
- Jan 22, 2026— Set$14.50price target onFOLD(Amicus Therapeutics, Inc.)
- Jan 2, 2025— Set$8.00price target onARDX(Ardelyx, Inc.)
- Jan 1, 2025— Set$80.00price target onRYTM(Rhythm Pharmaceuticals, Inc.)
- Nov 8, 2024— Set$8.00price target onIKT(Inhibikase Therapeutics, Inc.)
- Sep 20, 2024— Set$35.00price target onASMB(Assembly Biosciences, Inc.)
- Sep 3, 2024— Set$6.00price target onRXRX(Recursion Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Dennis Ding?
Dennis Ding is a stock analyst at Jefferies covering 8 stocks primarily in Healthcare. They have issued 9 price targets since Sep 3, 2024.
What stocks does Dennis Ding cover?
Dennis Ding currently covers 8 stocks, including RYTM, MLYS, SGP, FOLD, ARDX.
What is Dennis Ding's latest price target?
Dennis Ding's most recent price target was $30.00 on MLYS (Mineralys Therapeutics, Inc.), set on Mar 13, 2026.
What is Dennis Ding's highest price target?
Dennis Ding's highest issued price target is $125.00 on RYTM, set on Mar 3, 2026.
More Analysts at Jefferies
Coverage based on publicly published price targets. Not investment advice.